ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135077; 2) Community: the network communities that were significantly associated with the response to NSC 135077; 3) Molecule: the relationships between components within communities and NSC 135077; 4) MDR: the compounds that were significantly associated with the NSC 135077.

NSC Compound Enrichment Correlation
NSC 744622 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide 0.0400159331976381 0.26294819
NSC 749151 Null 0.0400159331976381 0.23761448
NSC 764043 (+)-JQ1 0.0400159331976381 0.028345454
NSC 93868 Naphtho[1,2-b]quinolizinium, 3,13-dimethyl- perchlorate 0.0400159331976381 -0.046805405
NSC 139105 Soluble Baker's Antifol 0.0430505868034761 0.26582242
NSC 149967 Null 0.0430505868034761 0.067238113
NSC 189793 Streptovaricin complex, fraction a 0.0430505868034761 0.17347568
NSC 249992 M-AMSA 0.0430505868034761 0.47204857
NSC 276371 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-[(3,7,11,15-tetramethyl-2-hexadecenyl)thio]-, [R-[R*,R*-(E)]]- 0.0430505868034761 0.25199476
NSC 29443 Null 0.0430505868034761 0.31104174
Total:126  Current:107    [First] [Prev] [Next] [Last]